Transaction · 0001662982-26-000006

Wang Xiaodong

Wang Xiaodong, DIR, reported a transaction classified as exercise at BeOne Medicines Ltd. involving 403351.000000 shares for an estimated $0.00. Reported holdings after the transaction were 403364.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MDIR
ONCBeOne Medicines Ltd.
Trade date
Oct 13, 2026
Filing date
Oct 15, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded403k$0.00 per share
Holdings after403kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ONC price since this filing

Daily closing prices, with the filing date and available return windows
ONC · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -7.4%1w ago -3.0%1d ago -6.3%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001662982-26-000006
Share Option (Right to Buy)
Transaction date
Oct 13, 2026
Filed Oct 15, 2026, 09:08 PM · 2d delay
Shares
403,351 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
403,364 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther Yes
Footnotes & amended
  1. F1

    These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.

  2. F2

    These securities are held by Wang Investment LLC, of which 99% of the limited liability company interests are owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a tr…

  3. F3

    These securities are held by the spouse of the Reporting Person.

  4. F4

    Each American Depositary Share represents 13 Ordinary Shares.

  5. F5

    The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026.

  6. F6

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.98 to $349.97, inclusive. The Reporting Person has provided to t…

  7. F7

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.98 to $350.97, inclusive. The Reporting Person has provided to t…

  8. F8

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.98 to $351.97, inclusive. The Reporting Person has provided to t…

  9. F9

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.99 to $352.95, inclusive. The Reporting Person has provided to t…

  10. F10

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.01 to $353.325, inclusive. The Reporting Person has provided to…

  11. F11

    The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

  12. F12

    These securities vest over a four-year period as follows: 25% on July 13, 2017, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject…

Original filing · 0001662982-26-000006
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ONC